Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin

SIMPLE SUMMARY: The treatment options for advanced well differentiated liposarcoma (WDLPS) and dedifferentiated liposarcoma (DDLPS) are scant, especially after the failure of first-line, anthracycline-based treatment, when trabectedin is one of the most active agents currently approved. Thus, the id...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Fabbroni, Chiara, Fucà, Giovanni, Ligorio, Francesca, Fumagalli, Elena, Barisella, Marta, Collini, Paola, Morosi, Carlo, Gronchi, Alessandro, Dei Tos, Angelo Paolo, Casali, Paolo Giovanni, Sanfilippo, Roberta
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8005098/
https://ncbi.nlm.nih.gov/pubmed/33810165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061453
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars